{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:42:15Z","timestamp":1770748935413,"version":"3.50.0"},"reference-count":7,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["Indian J Dermatol Venereol Leprol"],"DOI":"10.25259\/ijdvl_790_2024","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T09:55:42Z","timestamp":1726221342000},"page":"115-116","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Guselkumab for psoriasis management in an HIV positive patient"],"prefix":"10.25259","volume":"91","author":[{"given":"Miaoqi","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunfei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"10.25259\/IJDVL_790_2024\/ref-1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM198511283132210","article-title":"AIDS exacerbates psoriasis","volume":"313","author":"Johnson","year":"1985","journal-title":"N Engl J Med."},{"key":"10.25259\/IJDVL_790_2024\/ref-2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bjd.15665","article-title":"British association of dermatologists guidelines for biologic therapy for psoriasis 2017","volume":"177","author":"Smith","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_790_2024\/ref-3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.02.042","article-title":"Use of biologic treatment in psoriasis patients with HIV: A systematic review","author":"Sood","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_790_2024\/ref-4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tim.2014.01.001","article-title":"A neglected epidemic: Fungal infections in HIV\/AIDS","volume":"22","author":"Armstrong-James","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.25259\/IJDVL_790_2024\/ref-5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2546161","article-title":"Short-term efficacy and safety of IL-17, IL-12\/23, and IL-23 inhibitors brodalumab, secukinumab, ixekizumab, ustekinumab, guselkumab, tildrakizumab, and risankizumab for the treatment of moderate to severe plaque psoriasis: A systematic review and network meta-analysis of randomized controlled trials","volume":"2019","author":"Bai","year":"2019","journal-title":"J Immunol Res"},{"key":"10.25259\/IJDVL_790_2024\/ref-6","doi-asserted-by":"publisher","first-page":"e00271","DOI":"10.1128\/JVI.00271-21","article-title":"Link between interleukin-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals","volume":"95","author":"Luo","year":"2021","journal-title":"J Virol"},{"key":"10.25259\/IJDVL_790_2024\/ref-7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: From discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/guselkumab-for-psoriasis-management-in-an-hiv-positive-patient\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/guselkumab-for-psoriasis-management-in-an-hiv-positive-patient\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T09:43:08Z","timestamp":1734946988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/guselkumab-for-psoriasis-management-in-an-hiv-positive-patient\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":7,"alternative-id":["10.25259\/IJDVL_790_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_790_2024","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"article-number":"115"}}